SC
QNRX

SummitTX Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

SummitTX Capital’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$662K Buy
100,300
+35,505
+55% +$322K 0.02% 523
2025
Q4 		$935K Buy
+64,795
New +$882K 0.03% 428

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SummitTX Capital's QNRX Position: Q1 2026 in Review

SummitTX Capital increased its Quoin Pharmaceuticals (QNRX) stake by 55% in Q1 2026, buying an estimated $322K and bringing the position to 100,300 shares worth $662K. The position accounts for 0.02% of the portfolio, ranked #523.

SummitTX Capital first reported a position in QNRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $935K in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • SummitTX Capital held 100,300 shares of Quoin Pharmaceuticals worth $662K as of Q1 2026.
  • SummitTX Capital bought 35,505 Quoin Pharmaceuticals shares in Q1 2026, an estimated $322K.
  • Quoin Pharmaceuticals made up 0.02% of SummitTX Capital's portfolio in Q1 2026, its #523 holding.
  • SummitTX Capital first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • SummitTX Capital's Quoin Pharmaceuticals position peaked at $935K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.